rs745895675
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM1PM5BP6BS2
The NM_000548.5(TSC2):c.4639G>A(p.Val1547Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,612,608 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1547G) has been classified as Pathogenic.
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249908Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135668
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1460394Hom.: 1 Cov.: 33 AF XY: 0.0000303 AC XY: 22AN XY: 726500
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Benign:3
- -
- -
This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -
not provided Uncertain:2
Identified as a somatic variant in the brain of a patient with focal cortical dysplasia type IIa; this patient did not have any features of TSC (Lim et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously reported as a pathogenic or benign germline variant to our knowledge; This variant is associated with the following publications: (PMID: 28215400, 18466115) -
- -
Isolated focal cortical dysplasia type II Pathogenic:1
- -
Tuberous sclerosis syndrome Uncertain:1
This missense variant replaces valine with isoleucine at codon 1547 of the TSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with TSC2-related disorders in the literature. This variant has been identified in 7/249908 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
TSC2-related disorder Uncertain:1
The TSC2 c.4639G>A variant is predicted to result in the amino acid substitution p.Val1547Ile. This variant was identified as a somatic variant in the brain of a patient with focal cortical dysplasia type IIa (Lim et al 2017. PubMed ID: 28215400). This variant is reported in 0.016% of alleles in individuals of South Asian descent in gnomAD. This variant has interpretations ranging from benign to pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/238056/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at